News|Articles|July 1, 2011

Formulary Digital Edition July 2011

Alzheimer's disease: Current treatment options and future developments; Focus on rivaroxaban: a novel oral factor Xa inhibitor to prevent stroke in nonvalvular atrial fibrillation

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.


Latest CME